Remove 2025 Remove Due Diligence Remove Healthcare information Technology
article thumbnail

Healthcare M&A Slowdown 2024: Alvarez & Marsal’s Raheel Khan on Market Challenges & 2025 Outlook

HIT Consultant

With extensive experience advising both buyers and sellers in the healthcare sector, Khan offers valuable insights into the forces shaping M&A activity, the challenges faced by market participants, and the opportunities that lie ahead in 2025. What key factors do you anticipate will influence healthcare M&A activity in 2025?